US EditionAstraZeneca ends manufacturing license at Indian plant as it exits the site
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AstraZeneca ends manufacturing license at Indian plant as it exits the site
AstraZeneca is terminating a manufacturing license at its factory in Bengaluru, India, after announcing its plans to sell the facility last year, a company spokesperson confirmed to Endpoints News. The manufacturing license at the site ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
